[72] Dihydropyridines including felodipine (Plendil), nicardipine (Cardene), nifedipine, nisoldipine (Sular) and nitrendipine (Bayotensin) [63] Erlotinib (Tarceva) [73] Exemestane, aromasin, and by extension all estrogen-like compounds and aromatase inhibitors that mimic estrogen in function will be increased in effect, causing increased estrogen retention and increased drug retention
10.18632/oncotarget.23640 65 KanoskiS
Check with your health care professional about dosing for your individual situation
NativePath the caloric restriction and appetite suppression that GLP-1 medications produce may affect structural tissue too - specifically bone mineral density and lean mass
Neurotherapeutics (2010) 7(3):28392
SGLT2 Inhibitors (SGLT2i) Kidney-Focused Regulation Mechanism: Works through the kidneys, independent of insulin signaling